Stockscreener 앱 받기
1.12
0.88%
-0.010
시간 외 거래:
1.12
전일 마감가:
$1.13
열려 있는:
$1.15
하루 거래량:
701.87K
Relative Volume:
1.01
시가총액:
$157.67M
수익:
$200.55M
순이익/손실:
$11.80M
주가수익비율:
12.89
EPS:
0.0869
순현금흐름:
$-26.13M
1주 성능:
+4.67%
1개월 성능:
-29.56%
6개월 성능:
-24.32%
1년 성능:
-18.25%
1일 변동 폭
$1.12
$1.15
1주일 범위
$1.04
$1.15
52주 변동 폭
$1.04
$2.24
Organigram Global Inc Stock (OGI) Company Profile
명칭
Organigram Global Inc
전화
-
주소
-
Compare OGI vs TAK, HLN, TEVA, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OGI
Organigram Global Inc
|
1.12 | 159.08M | 200.55M | 11.80M | -26.13M | 0.0869 |
TAK
Takeda Pharmaceutical Co Adr
|
16.25 | 52.07B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.29 | 41.28B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.07 | 39.78B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
81.32 | 33.57B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
568.43 | 24.02B | 3.17B | 1.29B | 1.01B | 27.09 |
Organigram Global Inc Stock (OGI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-27 | 개시 | Canaccord Genuity | Buy |
| 2024-07-17 | 재개 | Canaccord Genuity | Speculative Buy |
| 2024-04-15 | 업그레이드 | Alliance Global Partners | Neutral → Buy |
| 2023-01-13 | 업그레이드 | Stifel | Hold → Buy |
| 2022-01-12 | 업그레이드 | Canaccord Genuity | Hold → Speculative Buy |
| 2021-05-11 | 업그레이드 | CIBC | Sector Underperform → Neutral |
| 2021-04-14 | 다운그레이드 | CIBC | Neutral → Sector Underperform |
| 2021-04-08 | 업그레이드 | BMO Capital Markets | Underperform → Market Perform |
| 2021-03-10 | 다운그레이드 | BMO Capital Markets | Market Perform → Underperform |
| 2021-01-13 | 다운그레이드 | Alliance Global Partners | Buy → Neutral |
| 2021-01-13 | 다운그레이드 | Canaccord Genuity | Speculative Buy → Hold |
| 2020-07-07 | 개시 | Alliance Global Partners | Buy |
| 2020-01-15 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-01-13 | 개시 | BofA/Merrill | Underperform |
| 2020-01-09 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-11-12 | 다운그레이드 | BMO Capital Markets | Outperform → Market Perform |
| 2019-11-05 | 개시 | Cantor Fitzgerald | Overweight |
| 2019-10-11 | 업그레이드 | Jefferies | Hold → Buy |
모두보기
Organigram Global Inc 주식(OGI)의 최신 뉴스
Top Lite Strategy (LITS) Competitors 2026 - MarketBeat
OGI Stock Price, Quote & Chart | ORGANIGRAM GLOBAL INC (NASDAQ:OGI) - ChartMill
Organigram CEO sees Germany as launchpad for European expansion - MJBizDaily
Organigram says vape weakness pressures margins - MSN
Organigram: Record Harvests Are The Root Of Market Share Erosion (NASDAQ:OGI) - Seeking Alpha
Buy this cannabis stock for a double, analyst says - Cantech Letter
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - marketexclusive.com
Organigram global Q2 earnings call highlights - MSN
Organigram Global Inc.Common Shares (NQ: OGI - The Chronicle-Journal
Cannabis selloff hits CRON, ACB, CGC, TLRY, OGI as reclassification seen limited - MSN
OrganiGram Holdings Reports Q2 2026 Results: Full Earnings Call Transcript - Sahm
Transcript: OrganiGram Holdings Q2 2026 Earnings Conference Call - Sahm
Organigram & Village Farms Earnings Breakdown - The Dales Report
Organigram global Q2 earnings preview - MSN
Organigram Says Vape Weakness Pressures Margins - Sahm
Organigram Holdings stock (CA68620P1018): Q2 2026 results show revenue drop, raised FY guidance - AD HOC NEWS
Organigram Global Sees FY26 Adjusted Ebitda, Adjusted Gross Margin Exceeding FY25 Performance >OGI - Moomoo
Small caps to watch: Boyd Group shares dive after earnings. Plus, Total Energy Services, AGT Food, Goeasy, Algoma Steel and more - The Globe and Mail
Organigram hits 52-week low after Q2 results - MSN
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Na - GuruFocus
MSN Money - MSN
Earnings Call Summary | Organigram Global Inc(OGI.CA) Q2 2026 Earnings Conference - Moomoo
Organigram Global Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2026 - marketscreener.com
Organigram Global Inc (OGI) Q2 2026 Earnings Call Highlights: Navigating Challenges and Seizing ... By GuruFocus - Investing.com Canada
Organigram Global Inc. 2026 Q2ResultsEarnings Call Presentation (TSX:OGI:CA) 2026-05-12 - Seeking Alpha
Organigram Global Q2 2026 Earnings Call Transcript - MarketBeat
Organigram Global Inc. Updates Revenue Guidance for the Fiscal Year 2026 - marketscreener.com
Organigram Global Inc. Reports Impairment of Property, Plant and Equipment, Intangible Assets and Goodwill for the Second Quarter Ended March 31, 2026 - marketscreener.com
Organigram Global Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Organigram stock hits 52-week low on Q2 results (OGI:NASDAQ) - Seeking Alpha
Organigram Global : INVESTOR PRESENTATION (dad9ab a7f6d4c8) - marketscreener.com
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI) - Yahoo Finance
Organigram Eyes International Growth with Sanity Group to Offset Q2 Revenue Drop - StratCann
OGI Reports Q2 Financials with Adjusted EBITDA Decline - GuruFocus
Organigram Global Q2 Earnings Call Highlights - MarketBeat
Earnings call transcript: OrganiGram posts Q2 2026 financial misses, stock dips - Investing.com
OrganiGram (OGI) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Organigram Global Files Q2 2026 Results as Sanity Group Deal Extends European Cannabis Reach - TipRanks
OGI: Operational challenges impacted Q2, but improvements and Sanity integration set up a stronger H2 - TradingView
Organigram Reports Second Quarter Fiscal 2026 Results - Business Wire
OGI Forecasts Strong FY26 Adjusted EBITDA and Low Capital Expend - GuruFocus
OrganiGram: Fiscal Q2 Earnings Snapshot - marketscreener.com
Organigram Global Swings to Q2 Net Loss, Net Revenue Falls; Updates Fiscal 2026 Guidance - marketscreener.com
Organigram (NASDAQ: OGI) buys Sanity Group and lifts 2026 outlook amid hemp risks - Stock Titan
Organigram Global : Press Release (dad9ab a96f5298) - marketscreener.com
Organigram Global Sees FY26 Free Cash Flow About Breakeven >OGI - Moomoo
Earnings Flash (OGI) Organigram Global Inc. Reports Q2 Net Loss $0.9M Vs Net Income of $42.5M in Q2 Fiscal 2025 - marketscreener.com
Organigram Q2 Adjusted EBITDA $0.9M, Down 82% YoY - marketscreener.com
Organigram Q2 Net Revenue $59.8M, Down 9% YoY - marketscreener.com
Press Release: Organigram Reports Second Quarter Fiscal 2026 Results - Moomoo
Organigram Global Inc (OGI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.92%
4.44%
자본화:
|
볼륨(24시간):